Zimmer MedizinSysteme
Junkersstraße 9, Neu-Ulm, Bayern, 89231, Germany
Overview
Zimmer Medizinsysteme offers system solutions in medical technology for diagnostics, therapy and aesthetic medicine. The company is an independent medium-sized company, we are committed to the location Germany, based in the innovation region Ulm / Neu-Ulm. The certification of the company is for us only the visible expression of our quality thinking. All employees are committed to our quality process, which ranges from development at the factory to on-site customer care.
- Total investments
- 1
- Lead investments
- 0
- Investments · 12mo
- 0
- Active investors
- 0
Sector focus
- Health Care
- Health Diagnostics
- Medical
- Medical Device
Investment portfolio
- Zimmer Medizinsysteme
Participated · Equity · Aug 2017
Zimmer BioTech is a drug-development spin-off from Zimmer MedizinSysteme GmbH based in Neu-Ulm, Germany. It is advancing Alevin deep, a drug based on 5‑Aminolevulinic acid (ALA) intended for use in treating actinic keratoses and as a therapy to combat skin cancer. The company has implemented a pharmaceutical-focused quality management system to meet legal requirements for drug development. Management plans to begin human clinical testing of Alevin deep in the near future, with regulatory approval anticipated in 2020. Financially, Zimmer BioTech raised funding to support continued development of the therapy. The spin-off structure and backing from its parent device producer inform its strategic and operational setup.
Team
No current team members are available.